Cargando…
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
Cell-based therapies are emerging as new promising treatments in stroke. However, their functional mechanism and therapeutic potential during early infarct maturation has so far received little attention. Here, we asked if cell-based delivery of the interleukin-1 receptor antagonist (IL-1Ra), a know...
Autores principales: | Clausen, Bettina Hjelm, Lambertsen, Kate Lykke, Dagnæs-Hansen, Frederik, Babcock, Alicia Anne, von Linstow, Christian Ulrich, Meldgaard, Michael, Kristensen, Bjarne Winther, Deierborg, Tomas, Finsen, Bente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835531/ https://www.ncbi.nlm.nih.gov/pubmed/26860727 http://dx.doi.org/10.1007/s00401-016-1541-5 |
Ejemplares similares
-
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
por: von Linstow, Christian Ulrich, et al.
Publicado: (2021) -
Post-stroke inflammation—target or tool for therapy?
por: Lambertsen, Kate Lykke, et al.
Publicado: (2018) -
Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice
por: Clausen, Bettina H, et al.
Publicado: (2008) -
Spontaneous ischaemic stroke lesions in a dog brain: neuropathological characterisation and comparison to human ischaemic stroke
por: Thomsen, Barbara Blicher, et al.
Publicado: (2017) -
Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling
por: Clausen, Bettina Hjelm, et al.
Publicado: (2016)